Understanding what each active ingredient does helps you have a more informed conversation with your clinician.
Terbinafine Strong Evidence
An allylamine antifungal that inhibits ergosterol synthesis in fungal cell membranes. Oral terbinafine accumulates in the nail plate for months after the treatment course ends. Complete cure approximately 38% in the FDA label trials (Lamisil prescribing information). Most potent option available; requires prescription and monitoring.
Undecylenic acid Limited Evidence
A fatty acid antifungal, FDA-approved for topical skin infections. Limited evidence for nail penetration. No systemic absorption and no known interactions with diabetes medications. Appropriate for mild surface-level cases as a first OTC option.
Tolnaftate Limited Evidence
A synthetic antifungal effective for athlete’s foot (tinea pedis). Limited evidence for nail-plate penetration. Useful for preventing spread to surrounding skin while treating the nail with a stronger option.
Efinaconazole (Jublia) Moderate Evidence
A prescription topical triazole with better nail-plate penetration than older lacquers. Complete cure rate 15–18% (Elewski et al., JAAD 2013). Topical application means lower systemic exposure compared to oral antifungals — a significant advantage for diabetics who cannot take oral options.
Tea tree oil Limited Evidence
Some in-vitro antifungal activity. Very limited clinical trial evidence for nail fungus. Not recommended as sole treatment. May irritate sensitive skin in some diabetics.